References
- Grunewald J, Eklund A. Sex-specific manifestations of Löfgren’s syndrome. Am J Respir Crit Care Med 2007;175(1):40-4.
- Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells 2021;10(4):766.
- Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician 2004;70(2):312-22.
- Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers 2019;5(1):45.
- Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018;9(11):227-40.
- Lofgren S, Lundback HF. The bilateral hilar lymphoma syndrome; a study of the relation to age and sex in 212 cases. Acta Med Scand 1952;142(4):259-64.
- Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of Sarcoidosis in Japan. Eur Respir J 2008;31(2):372-9.
- Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, et al. The diagnostic pathway to sarcoidosis. Chest 2003;123(2):406-12.
- Sinha A, Lee KK, Rafferty GF, Yousaf N, Pavord ID, Galloway J, et al. Predictors of objective cough frequency in pulmonary sarcoidosis. Eur Respir J 2016;47(5):1461-71.
- Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009;20(5):578-83.
- Tunariu N, Gibbs SJ, Win Z, Gin-Sing W, Graham A, Gishen P, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48(5):680-4.
- Meng JJ, Zhang LJ, Wang Q, Fang W, Dai HJ, Yan J, et al. A comparison of ventilation/perfusion single photon emission CT and CT pulmonary angiography for diagnosis of pulmonary embolism. Zhonghua Jie He He Hu Xi Za Zhi 2013;36(3):177-81.
- Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009;104(4):571-7.
- Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011;183(11):1524-30.
- Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med 1995;119(2):167-72.
- Martusewicz-Boros M, Wiatr E, Piotrowska-Kownacka D, Tomkowski W, Roszkowski-Sliz K. Sarkoidoza z zajęciem serca – doświadczenia własne. Pneumonol Alergol Pol 2007;75(1):100-7.
- Adler Y, Charron P. The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 2015;36(42):2873-4.
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42(36):3599-726.
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018;72(18):2231-64.
- Baba Y, Kubo T, Kitaoka H, Okawa M, Yamanaka S, Kawada Y, et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int Heart J 2012;53(5):287-92.
- Kiko T, Yoshihisa A, Kanno Y, Yokokawa T, Abe S, Miyata-Tatsumi M, et al. A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis. Int Heart J 2018;59(5):996-1001.
- Dubrey SW, Sharma R, Underwood R, Mittal T. Cardiac sarcoidosis: diagnosis and management. Postgrad Med J 2015;91(1077):384-94.
- Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr, Prystowsky EN, et al. Cardiac sarcoidosis. Am Heart J 2009;157(1):9-21.
- Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J 1961;2(5261):1165-72.
- Antczak A, editor. Wielka Interna Pulmonologia. Część 1. Warszawa: Medical Tribune Polska; 2018.
- Boros P, Franczuk M, Wesołowski S. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące wykonywania badań spirometrycznych. Pneumonol Alerg Pol 2006;74:1-44.
- Płońska-Gościniak E, editor. Standardy kardiologiczne 2020 okiem echokardiografisty. Wyd. 1. Warszawa: Medical Tribune Polska; 2020.
- Lipiec P, Hoffman P, editors. Echokardiografia klinczna. Podręcznik Sekcji Echokardiografii Polskiego Towarzystwa Kardiologicznego. Wyd. 1. Warszawa: i-medica; 2017.
- Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015;46(4):903-75.
- Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005;150(3):459-63.
- Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008;133(6):1426-35.
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37(27):2129-200.
- Baum C, Ojeda FM, Wild PS, Rzayeva N, Zeller T, Sinning CR, et al. Sub-clinical impairment of lung function is related to mild cardiac dysfunction and manifest heart failure in the general population. Int J Cardiol 2016; 218:298-304.
- Andrea R, López-Giraldo A, Falces C, Sobradillo P, Sanchis L, Gistau C, et al. Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction. Heart Lung Circ 2014;23(3):273-9.
- Martusewicz-Boros MM, Boros PW, Wiatr E, Zych J, Kempisty A, Kram M, et al. Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study. Medicine (Baltimore) 2019;98(47):e18037.
- Rodrigues SC, Rocha NA, Lima MS, Arakaki JS, Coletta EN, Ferreira RG, et al. Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil. Sarcoidosis Vasc Diffuse Lung Dis 2011;28(1):34-43.
- Inoue Y, Inui N, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, et al. Cumulative incidence and predictors of progression in corticosteroid-naïve patients with sarcoidosis. PLoS One 2015;10(11):e0143371.
- Kasapkara HA, Şentürk A, Bilen E, Duran Karaduman B, Ayhan H, Özen MB, et al. The usefulness of left atrial volume index and left ventricular mass index in determining subclinical cardiac involvement in patients with early-stage sarcoidosis. Ir J Med Sci 2016;185(3):617-21.
- Daoud A, Pervaiz A, Samavati L. Clinical risk factors for cardiac sarcoidosis. Chest 2019;156(4 Suppl):a1706.
- Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993;6(3):349-53.
- Boros PW, Enright PL, Quanjer PH, Borsboom GJ, Wesolowski SP, Hyatt RE. Impaired lung compliance and DL,CO but no restrictive ventilatory defect in sarcoidosis. Eur Respir J 2010;36(6):1315-22.
- Diaz-Guzman E, Farver C, Parambil J, Culver DA. Pulmonary hypertension caused by sarcoidosis. Clin Chest Med 2008;29(3):549-63.
- Katsushika S, Kodera S, Nakamoto M, Ninomiya K, Kakuda N, Shinohara H, et al. Deep learning algorithm to detect cardiac sarcoidosis from echo-cardiographic movies. Circ J 2021;86(1):8.